Dr Samba Reddy, Professor, Texas A&M College of Medicine, receives with Lifetime Achievement Award

▴ Dr. Samba Reddy
Dr Samba Reddy honored with Lifetime achievement awards

Dr. Samba Reddy, Phd, RPh,  professor of neuroscience and experimental therapeutics at the Texas A&M College of Medicine has been conferred with the Lifetime Achievement Award at the 13th annual convention of ABAP & International Biotechnology Conference in Vijayawada .Dr Reddy received this  honour for his highly coveted scientific research and  service to the profession in the field of pharmacy. The award and gold medal were presented to Dr Reddy at by Dr Appa Rao, Vice-Chancellor of University of Hyderabad and Dr KS Rao, Vice-Chancellor of Mizoram Central University, India.

He teaches both medical and graduate level courses and directs a research team in central nervous system drug development. Dr. Reddy has made exceptional contributions to the pharmaceutical field through his services during the past 20 years, in addition to serving as an expert member in federal government panels in Washington D.C.

He is a highly trained pharmacist-pharmacologist developing new therapeutics for epilepsy and chemical neurotoxicity. He is developing new drugs for epilepsy and brain disorders, and his research has been continuously funded by the National Institutes for Health (NIH) for over 14 years. He is the principal investigator of an NIH project focusing on novel treatments for organophosphate and chemical nerve agent intoxication, and he directs a Department of Defense project on post-traumatic epilepsy after traumatic brain injury.

Dr. Reddy was elected fellow of three leading scientific organizations --the American Association of Pharmaceutical Scientists (AAPS), the American Association for the Advancement of Science (AAAS), and the American Epilepsy Society (AES) for his outstanding contributions to pharmacology and epilepsy neuroscience research.

Dr. Reddy won a number of awards for his research excellence, including the NIH Research Excellence Award (2000), ASPET Award (2004), Sigma-Xi Research Award (2006), ASIOA Award (2007), NATA Research Award (2012), TANA Award (2013), ATA Science Award (2014), and Texas A&M Medicine Research Excellence Award (2015).

Dr. Reddy has been conferred with a Telangana Science Achievement award for his pioneering (lifetime) contributions in discovering new treatments for brain diseases. He serves as expert member and adviser for federal scientific committees, including the NIH, DOD, EPA and USP.

 

Dr. Reddy received his doctorate in pharmacology from Panjab University in Chandigarh, India. He completed his postdoctoral fellowship with the National Institutes of Health in Bethesda, Maryland.

He serves as expert member and adviser for federal scientific committees, including the NIH, DOD, EPA and USP.

Tags : #drsambareddy #life #time #achievement #award #medicircle

Related Stories

24 Nov

Power of the Gut - Microbiome testing of Leucine Rich Bio

The microbes present in our gastrointestinal speaks volumes about the way we feel and more about our health. It is to uncover more about this gut that three people together started Leucine Rich Bio.

View
30 Apr

Vetter and Rentschler Biopharma further strengthen their strategic alliance

The alliance would result in the alignment of manufacturing approaches that enable clients to bring their products to patients more easily and faster.

View
10 Jun

Frost & Sullivan names top innovators in AI for drug discovery

The Frost Radar benchmarks the top 16 companies in the market excelling at growth and innovation

View
15 May

Frost & Sullivan Assesses the Top 21 Global Risks

Frost & Sullivan assesses the Top 21 global risks that threaten the next decade due to COVID-10 pandemic

View
24 Apr

J&J Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine

COVID-19 belongs to a group of viruses called coronaviruses that attack the respiratory system. There is currently no approved vaccine, treatment or cure for COVID-19.

View
26 Mar

Production Units of Indian Railways asked to explore possibilities to manufacture essential medical items, in case of need

Railway Board has entrusted the General Managers to explore the feasibility in consultation with Principal Chief Medical Director of the zone/production unit for manufacture of these items in large quantities as may be required at short notice.

View
04 Mar

Frost & Sullivan Defines Top Femtech Global Opportunities by 2024

Technologies such as mHealth, telehealth, and wearable devices to help pregnancy care, fertility, and menstrual care treatments while reducing costs

View
27 Feb

Frost & Sullivan, Projects Manufacturing Organization Market will Reach $102.14 Billion by 2024

Advancements in flexible manufacturing technology to help address new demand in personalized medicine, reports Frost & Sullivan

View
13 Feb

Focus on Natural Skin Care Products Triggers Demand for Suitable Preservatives : Frost & Sullivan

Social media influence and natural ingredients trend will boost growth opportunities for manufacturers, finds Frost & Sullivan

View
12 Feb

Frost & Sullivan Receives 2020 Global Company of the Year Award

Genomenon Commended by Frost & Sullivan for Advancing Clinical Genomics Interpretation and Personalized Medicine with Its Mastermind Platform

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025